Back to top

Analyst Blog

Recently, Aetna Inc. (AET - Analyst Report) completed the acquisition of Coventry Health Care Inc., which was announced in August last year. As a result, Aetna raised its operating earnings guidance for 2013 to $5.70–$5.85 per share from $5.50–$5.60 per share estimated earlier.

Impact of the Acquisition

Aetna believes that the acquisition will enhance its financial and strategic expertise to meet the evolving needs of customers. The takeover has expanded the government programs business of the company.

As a result, Aetna’s medical membership has increased by 3.7 million and its Medicare Part D enrollment has surged by 1.5 million. Additionally, its Medicaid membership crossed the 2 million mark, rising from 1.1 million earlier.

Moreover, Aetna’s Medicaid business now has presence in 16 states, compared with 12 states earlier. The company has been focusing on expanding its government programs, apart from vertical and horizontal expansion of its insurance business, as the government programs business is currently undergoing rapid growth.

Rating Changes

As a result of the closure of the deal, Fitch Ratings has affirmed the issuer default rating of Aetna at “A” and the insurer financial strength rating of its operating subsidiaries at “AA-“. Additionally, the rating agency removed these ratings from “Rating Watch Negative”. However, these ratings still carry a negative outlook.


On Aug 20, 2012, Aetna signed an agreement to acquire Coventry Health for $7.3 billion. The purchase consideration also includes the takeover of the latter’s debt.

As per the agreement, shareholders of Coventry Health will get a cash consideration of $27.30, along with 0.3885 Aetna shares, for each Coventry Health share. This translates into a total purchase consideration of $42.08 per share, based on the closing price of Aetna’s shares on Aug 17, 2012.

Aetna financed the cash component of the purchase consideration using a variety of sources, including cash in hand at the companies as well as new debt and commercial paper issued by Aetna.

Zacks Rank

Aetna currently carries a Zacks Rank #2 (Buy). Other health maintenance organizations worth considering are Molina Healthcare Inc. (MOH - Analyst Report), Health Net Inc. (HNT - Analyst Report) and Humana Inc. (HUM - Analyst Report). Both these companies carry a Zacks Rank #2 (Buy).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
TRIQUINT SE… TQNT 20.62 +6.29%
RF MICRO DE… RFMD 12.43 +5.65%
VASCO DATA… VDSI 14.84 +5.17%
STRATTEC SE… STRT 81.23 +4.27%
PATTERSON-U… PTEN 34.41 +2.58%